Abstract

Introduction: Coronary Heart Disease (CHD) is already established as a prominent cause of morbidity and mortality in India. Deaths due to cardiovascular diseases especially CHD accounts for about 30.9% of total Indian deaths caused by noncommunicable diseases. Objectives: To determine the prevalence of CHD and other associated co-morbidities in Delhi-NCR population and furthermore to study the prescription pattern and pharmacoeconomic burden of CHD patients in Delhi-NCR hospitals. Methodology: A cross sectional study was conducted on total of 980 patients taking treatment from hospitals in Delhi. The study utilized a pre designed questionnaire. Informed oral consent was obtained from every patient prior to getting their information relevant to the study. Results: Among 980 CHD patients studied, 643 were males and 337 were females. The disease showed to be more prevalent in the age group of 40-50 years in males and 50-60 years in females. Hypertension (HTN) was found to be most common comorbidity in CHD patients with 51.42 % followed by diabetes with 32.44 % prevalence. Medication: Aspirin (84.48 %) and atorvastatin (81.12 %) were observed to be most frequently prescribed drug for management of CHD. Metoprolol was the most preferred beta blocker. The most widely used anti-diabetic drug was metformin (19.89 %) and glimepiride (15%). The pharmacoeconomic burden on a CHD patient taking treatment in Delhi-NCR was estimated to be INR 1733 only per month. Conclusion: CHD was reasonably correlated with HTN and diabetes. Multiple medicines were used to manage CHD. The study also suggested the high probability of smoking to be a significant risk factor in males and sedentary life styles in females.